COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,668 Articles (22,913 medRxiv, 8,755 bioRxiv)

Most recent first Previous |  Page 320: Articles 3191-3200  | Next

The kinetics of SARS-CoV-2 nsp7-11 polyprotein processing and impact on complexation with nsp16
Schamoni-Kast, K., Krichel, B., Damjanovic, T., Kierspel, T., Toker, S., Uetrecht, C.
10.1101/2024.01.06.574466 — Posted: 2024-01-08
Post-Market Surveillance of Six COVID-19 Point-of-Care Tests Using Pre-Omicron and Omicron SARS-CoV-2 Variants
Exner, H. M., Gregorchuk, B. S. J., Castor, A.-G., Crisostomo, L., Kolsun, K., Giesbrecht, S., Dust, K., Alexander, D., Bolaji, A., Quill, Z., Head, B. M., Meyers, A. F. A., Sandstrom, P., Becker, M. G.
10.1101/2024.01.05.24300772 — Posted: 2024-01-07
Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection
Guenther, T., Schoefbaenker, M., Lorentzen, E. U., Romberg, M.-L., Hennies, M. T., Neddermeyer, R., Mueller, M. M., Mellmann, A., Lenz, G., Stelljes, M., Hrincius, E. R., Vollenberg, R., Ludwig, S., Tepasse, P.-R., Kuehn, J. E.
10.1101/2024.01.06.24300890 — Posted: 2024-01-07
Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection
Ko, S. H., Radecki, P., Belinky, F., Bhiman, J., Meiring, S., Kleynhans, J., Amoako, D., Guerra Canedo, V., Lucas, M., Kekana, D., Martinson, N., Lebina, L., Everatt, J., Tempia, S., Bylund, T., Rawi, R., Kwong, P., Wolter, N., von Gottberg, A., Cohen, C., Boritz, E. A.
10.1101/2024.01.05.574420 — Posted: 2024-01-06
CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells and its pulmonary levels correlate with viral clearance in critical COVID-19 patients
Barbosa Bomfim, C. C., Genin, H., Cottoignies-Callamarte, A., Gallois-Montbrun, S., Murigneux, E., Sams, A., Rozenberg, A. R., Belouzard, S., Dubuisson, J., Kosminder, O., Pene, F., Terrier, B., Bomsel, M., Ganor, Y.
10.1101/2024.01.05.574360 — Posted: 2024-01-06
Time to publication in medical education journals: An analysis of publication timelines during COVID-19 (2019-2022)
Maggio, L. A., Costello, J. A., Brown, K. R., Artino, A. R., Durning, S. J., Ma, T.
10.1101/2024.01.04.24300847 — Posted: 2024-01-05
Antigen-display exosomes provide adjuvant-free protection against SARS-CoV-2 disease at nanogram levels of spike protein
Guo, C., Sachithanandham, J., Zhong, W., Craney, M., Villano, J., Pekosz, A., Gould, S.
10.1101/2024.01.04.574272 — Posted: 2024-01-05
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression
Medina, M. A., Fuentes-Villalobos, F., Quevedo, C., Aguilera, F., Riquelme, R., Rioseco, M. L., Barria, S., Pinos, Y., Calvo, M., Burbulis, I., Alvarez, R. A., Garrido, J. L., Barria, M. I.
10.1101/2024.01.02.573936 — Posted: 2024-01-05
Automated Classification of At-home SARS-CoV-2 Lateral Flow Assay Test Results using Image Matching and Transfer Learning: multiple-pipeline study
Safarzadeh, M., Herbert, C., Wong, S. K., Stamegna, P., Guilarte-Walker, Y., Wright, C., Suvarna, T., Nowak, C., Kheterpal, V., Pandey, S., Wang, B., Lin, H., O'Connor, L., Hafer, N., Luzuriaga, K., Manabe, Y., Broach, J., Zai, A. H., McManus, D. D., Du, X., Soni, A.
10.1101/2024.01.04.24300836 — Posted: 2024-01-04
Mutation of highly conserved residues in loop 2 of the coronavirus macrodomain demonstrates that enhanced ADP-ribose binding is detrimental to infection
Kerr, C. M., Pfannenstiel, J. J., Alhammad, Y. M., Roy, A., O'Connor, J. J., Ghimire, R., Khattabi, R., Shrestha, R., McDonald, P. R., Gao, P., Johnson, D. K., More, S., Channappanavar, R., Fehr, A. R.
10.1101/2024.01.03.574082 — Posted: 2024-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).